Business Description
Viyash Scientific Ltd
ISIN : INE807F01027
Total Employee Number:
1,432Compare
Compare
Traded in other countries / regions
512529.India IPO Date
2016-03-10Description
Viyash Scientific Ltd is a pharmaceutical company with activities spanning formulations, active pharmaceutical ingredients (APIs), and intermediates. It is focused on research and development infrastructure for APIs and formulations. Its product portfolio spans several therapeutic areas, including ARV, cardiovascular, central nervous system, analgesics, antibiotics, antihistamines, diabetes, gastrointestinal, anticoagulants, and oncology.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.56 | |||||
Equity-to-Asset | 0.63 | |||||
Debt-to-Equity | 0.17 | |||||
Debt-to-EBITDA | 1.07 | |||||
Interest Coverage | 5.43 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 6.22 | |||||
Beneish M-Score | -0.64 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10.9 | |||||
3-Year Book Growth Rate | 33.5 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 90.77 | |||||
9-Day RSI | 81.85 | |||||
14-Day RSI | 75.71 | |||||
3-1 Month Momentum % | 29.33 | |||||
6-1 Month Momentum % | 17.82 | |||||
12-1 Month Momentum % | 33.41 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.38 | |||||
Quick Ratio | 1.53 | |||||
Cash Ratio | 0.29 | |||||
Days Inventory | 156.2 | |||||
Days Sales Outstanding | 84.29 | |||||
Days Payable | 105.14 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -20.5 | |||||
Shareholder Yield % | -1.38 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 52.67 | |||||
Operating Margin % | 12.1 | |||||
Net Margin % | 4.52 | |||||
EBITDA Margin % | 17.38 | |||||
FCF Margin % | 7.12 | |||||
OCF Margin % | 12.21 | |||||
ROE % | 8.11 | |||||
ROA % | 4.51 | |||||
ROIC % | 9.1 | |||||
3-Year ROIIC % | 10.8 | |||||
ROC (Joel Greenblatt) % | 22.97 | |||||
ROCE % | 15.49 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 92.52 | |||||
PE Ratio without NRI | 77.04 | |||||
Shiller PE Ratio | 82.3 | |||||
Price-to-Owner-Earnings | 2028.97 | |||||
PS Ratio | 3.97 | |||||
PB Ratio | 4.41 | |||||
Price-to-Tangible-Book | 6.6 | |||||
Price-to-Free-Cash-Flow | 69.11 | |||||
Price-to-Operating-Cash-Flow | 40.28 | |||||
EV-to-EBIT | 42.79 | |||||
EV-to-Forward-EBIT | 26.46 | |||||
EV-to-EBITDA | 28.87 | |||||
EV-to-Forward-EBITDA | 17.54 | |||||
EV-to-Revenue | 5.02 | |||||
EV-to-Forward-Revenue | 1.8 | |||||
EV-to-FCF | 70.47 | |||||
Price-to-GF-Value | 1.71 | |||||
Price-to-Projected-FCF | 4.12 | |||||
Price-to-Median-PS-Value | 1.82 | |||||
Price-to-Graham-Number | 4.76 | |||||
| Price-to-Net-Current-Asset-Value | 23.9 | |||||
Earnings Yield (Greenblatt) % | 2.34 | |||||
FCF Yield % | 1.47 | |||||
Forward Rate of Return (Yacktman) % | 12.75 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Viyash Scientific Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 26,437.8 | ||
| EPS (TTM) (₹) | 3.18 | ||
| Beta | 1.4093 | ||
| 3-Year Sharpe Ratio | 0.81 | ||
| 3-Year Sortino Ratio | 1.63 | ||
| Volatility % | 41.21 | ||
| 14-Day RSI | 75.71 | ||
| 14-Day ATR (₹) | 10.897587 | ||
| 20-Day SMA (₹) | 263.97 | ||
| 12-1 Month Momentum % | 33.41 | ||
| 52-Week Range (₹) | 166 - 297 | ||
| Shares Outstanding (Mil) | 436.46 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Viyash Scientific Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Viyash Scientific Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| Second quarter earnings conference call for 2027 | 2026-11-19 09:00 | In 137 days | ||
| Second quarter earnings results for 2027 | 2026-11-19 | In 136 days | ||
| First quarter earnings conference call for 2027 | 2026-08-11 09:00 | In 37 days | ||
| First quarter earnings results for 2027 | 2026-08-11 | In 36 days | ||
| General meeting for 2026 | 2026-08-07 16:00 | In 33 days | ||
| Annual report for 2026 | 2026-07-16 | In 10 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-05-20 16:00 | 228.73 (+0.31%) | ||
| Fourth quarter earnings results for 2026 | 2026-05-20 | 228.73 (+0.31%) | ||
| Third quarter earnings conference call for 2026 | 2026-02-06 17:30 | 208.95 (-3.71%) | ||
| Third quarter earnings results for 2026 | 2026-02-06 | 208.95 (-3.71%) |
Show
Entries
Viyash Scientific Ltd Frequently Asked Questions
What is Viyash Scientific Ltd(NSE:VIYASH)'s stock price today?
The current price of NSE:VIYASH is ₹294.15. The 52 week high of NSE:VIYASH is ₹297.00 and 52 week low is ₹166.00.
When is next earnings date of Viyash Scientific Ltd(NSE:VIYASH)?
The next earnings date of Viyash Scientific Ltd(NSE:VIYASH) is 2026-08-11 Est..
Does Viyash Scientific Ltd(NSE:VIYASH) pay dividends? If so, how much?
Viyash Scientific Ltd(NSE:VIYASH) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Viyash Scientific Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers